Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Correction: Emergence of Prions Selectively Resistant to Combination Drug TherapyPLoS pathogens, 2024-01, Vol.20 (1), p.e1011919-e1011919 [Peer Reviewed Journal]Copyright: © 2024 Burke et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;2024 Burke et al 2024 Burke et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1011919 ;PMID: 38190351Full text available |
|
2 |
Material Type: Article
|
Network-based prediction of drug combinationsNature communications, 2019-03, Vol.10 (1), p.1197-11, Article 1197 [Peer Reviewed Journal]This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-09186-x ;PMID: 30867426Full text available |
|
3 |
Material Type: Article
|
Uterotonic agents for preventing postpartum haemorrhage: a network meta‐analysisCochrane database of systematic reviews, 2018-12, Vol.2018 (12), p.CD011689 [Peer Reviewed Journal]Copyright © 2018 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD011689.pub3 ;PMID: 30569545Full text available |
|
4 |
Material Type: Article
|
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trialsThe Lancet (British edition), 2020-07, Vol.396 (10244), p.121-128 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30748-0 ;PMID: 32446323Full text available |
|
5 |
Material Type: Article
|
Diagnosis and management of pemphigus: Recommendations of an international panel of expertsJournal of the American Academy of Dermatology, 2020-03, Vol.82 (3), p.575-585.e1 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0190-9622 ;EISSN: 1097-6787 ;DOI: 10.1016/j.jaad.2018.02.021 ;PMID: 29438767Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Effect of IBD medications on COVID-19 outcomes: results from an international registryGut, 2021-04, Vol.70 (4), p.725-732 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2020-322539 ;PMID: 33082265Full text available |
|
7 |
Material Type: Article
|
SynergyFinder 2.0: visual analytics of multi-drug combination synergiesNucleic acids research, 2020-07, Vol.48 (W1), p.W488-W493 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research. ;info:eu-repo/semantics/openAccess ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gkaa216 ;PMID: 32246720Full text available |
|
8 |
Material Type: Article
|
Intramuscular AZD7442The New England journal of medicine, 2022-06, Vol.386 (23), p.2188 [Peer Reviewed Journal]COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406Full text available |
|
9 |
Material Type: Article
|
Optimum duration of regimens for Helicobacter pylori eradicationCochrane database of systematic reviews, 2013-12, Vol.2013 (12), p.CD008337-CD008337 [Peer Reviewed Journal]Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD008337.pub2 ;PMID: 24338763Full text available |
|
10 |
Material Type: Article
|
Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with CannabigerolMedicina (Kaunas, Lithuania), 2019-11, Vol.55 (11), p.747 [Peer Reviewed Journal]2019 by the authors. 2019 ;ISSN: 1648-9144 ;ISSN: 1010-660X ;EISSN: 1648-9144 ;DOI: 10.3390/medicina55110747 ;PMID: 31752240Full text available |
|
11 |
Material Type: Article
|
Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implicationsDiabetes & metabolism, 2019-12, Vol.45 (6), p.517-527 [Peer Reviewed Journal]2019 Elsevier Masson SAS ;Copyright © 2019 Elsevier Masson SAS. All rights reserved. ;ISSN: 1262-3636 ;EISSN: 1878-1780 ;DOI: 10.1016/j.diabet.2019.04.002 ;PMID: 31005756Full text available |
|
12 |
Material Type: Article
|
Helicobacter pylori eradication for the prevention of gastric neoplasiaCochrane database of systematic reviews, 2015-07, Vol.2015 (7), p.CD005583 [Peer Reviewed Journal]Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD005583.pub2 ;PMID: 26198377Full text available |
|
13 |
Material Type: Article
|
Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluationCritical care (London, England), 2018-10, Vol.22 (1), p.283-7, Article 283 [Peer Reviewed Journal]The Author(s). 2018 ;ISSN: 1364-8535 ;EISSN: 1466-609X ;DOI: 10.1186/s13054-018-2217-4 ;PMID: 30373647Full text available |
|
14 |
Material Type: Article
|
Systemic treatments for metastatic cutaneous melanomaCochrane database of systematic reviews, 2018-02, Vol.2020 (11), p.CD011123 [Peer Reviewed Journal]Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD011123.pub2 ;PMID: 29405038Full text available |
|
15 |
Material Type: Article
|
Primary, Adaptive, and Acquired Resistance to Cancer ImmunotherapyCell, 2017-02, Vol.168 (4), p.707-723 [Peer Reviewed Journal]2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2017.01.017 ;PMID: 28187290Full text available |
|
16 |
Material Type: Article
|
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical AssessmentAntimicrobial agents and chemotherapy, 2015-08, Vol.59 (8), p.4719-4726 [Peer Reviewed Journal]Copyright © 2015, American Society for Microbiology. All Rights Reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/aac.00835-15 ;PMID: 26014949Full text available |
|
17 |
Material Type: Article
|
The Efficacy of an N-Acetylcysteine–Antibiotic Combination Therapy on IAchromobacter xylosoxidans/I in a Cystic Fibrosis Sputum/Lung Cell ModelBiomedicines, 2022-11, Vol.10 (11) [Peer Reviewed Journal]COPYRIGHT 2022 MDPI AG ;ISSN: 2227-9059 ;EISSN: 2227-9059 ;DOI: 10.3390/biomedicines10112886Full text available |
|
18 |
Material Type: Article
|
Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attackCochrane database of systematic reviews, 2020-08, Vol.2020 (9), p.CD009716 [Peer Reviewed Journal]Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD009716.pub2 ;PMID: 32813275Full text available |
|
19 |
Material Type: Article
|
Phase I study of the 177 Lu-DOTA 0 -Tyr 3 -Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lungJournal for immunotherapy of cancer, 2020-07, Vol.8 (2), p.e000980 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2051-1426 ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2020-000980 ;PMID: 32616557Full text available |
|
20 |
Material Type: Article
|
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 MutationsThe New England journal of medicine, 2012-11, Vol.367 (18), p.1694-1703 [Peer Reviewed Journal]Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;Copyright © 2012 Massachusetts Medical Society. All rights reserved. 2012 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1210093 ;PMID: 23020132 ;CODEN: NEJMAGFull text available |